Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation

Bibliographic Details
Main Authors:	Hu, M, Basssett, J, Danks, L, Spanoudakis, E, Xu, K, Howell, P, Boyde, A, Horwood, N, Williams, G, Roberts, I, Karadimitris, A
Format:	Journal article
Published:	2008

Similar Items

Activated invariant NKT cells regulate osteoclast development and function.
by: Hu, M, et al.
Published: (2011)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
by: Kotsianidis, I, et al.
Published: (2006)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
by: Kotsianidis, I, et al.
Published: (2005)

Human invariant NKT cells are required for effective in vitro alloresponses.
by: Patterson, S, et al.
Published: (2005)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors
by: Patterson, S, et al.
Published: (2008)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
by: Patterson, S, et al.
Published: (2008)

Expression of Bruton's tyrosine kinase in osteoclasts
by: Danks, L, et al.
Published: (2005)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1D interaction and killer immunoglobulin receptors
by: Patterson, S, et al.
Published: (2008)

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
by: Anastasios Karadimitris, et al.
Published: (2019-06-01)

Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
by: Salio, M, et al.
Published: (2011)

The role of invariant NKT cells at the interface of innate and adaptive immunity
by: Cerundolo, V
Published: (2010)

The role of invariant NKT cells at the interface of innate and adaptive immunity.
by: Cerundolo, V, et al.
Published: (2010)

The Tec kinases: Bmx and Btk play distinct regulatory roles in osteoclast differentiation
by: Danks, L, et al.
Published: (2005)

NK cells support osteoclast formation in vitro
by: Danks, L, et al.
Published: (2005)

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids
by: Xu, K, et al.
Published: (2009)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
by: Ersek, A, et al.
Published: (2015)

Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts.
by: Danks, L, et al.
Published: (2011)

Harnessing invariant NKT-cells to enhance antigen specific immune responses
by: Cerundolo, V
Published: (2014)

NK cells support osteoclast formation in vitro
by: Owen, S, et al.
Published: (2004)

Harnessing invariant NKT cells in vaccination strategies.
by: Cerundolo, V, et al.
Published: (2009)

Lack of Bruton's tyrosine kinase results in osteoporosis, despite defects in osteoclast function
by: Danks, L, et al.
Published: (2007)

NKT cell networks in the regulation of tumor immunity
by: Faith C Robertson, et al.
Published: (2014-10-01)

NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer
by: Somayeh Rezaeifard, et al.
Published: (2019-12-01)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
by: Benjamin J. Wolf, et al.
Published: (2018-03-01)

Reduced bone density in XLA patients, an effect of B cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Reduced bone density in XLA patients, an effect of b-cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Essential role for autophagy during invariant NKT cell development
by: Salio, M, et al.
Published: (2014)

Human CD4- invariant NKT lymphocytes regulate graft versus host disease
by: Tereza Coman, et al.
Published: (2018-11-01)

Homeostatic regulation of marginal zone B cells by invariant natural killer T cells.
by: Xiangshu Wen, et al.
Published: (2011-01-01)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
by: Felix Scheuplein, et al.
Published: (2015-01-01)

Characterization and Functional Analysis of Mouse Invariant Natural T (iNKT) Cells
by: Bezbradica, J, et al.
Published: (2006)

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
by: Reddy, BG, et al.
Published: (2009)

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
by: Amanda C Stanley, et al.
Published: (2008-02-01)

Invariant NKT cell response to dengue virus infection in human.
by: Ponpan Matangkasombut, et al.
Published: (2014-06-01)

Osteoclast defects in XLA patients are negated by lack of mature B cells and elevated inflammatory cytokine production
by: Danks, L, et al.
Published: (2009)

Osteoclast defects in XLA patients are negated by the lack of mature B cells and elevated inflammatory cytokine production
by: Danks, L, et al.
Published: (2009)

Osteoclast activity regulates the size of the haematopoietic stem cell pool
by: Ersek, A, et al.
Published: (2011)

Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-γ production in mice.
by: Ji Hyung Kim, et al.
Published: (2012-01-01)

The complement system and invariant natural killer T (iNKT) cell responses
by: Malik, N
Published: (2021)